HGCSG1301: A multicenter, double-blind, randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment

Annals of Oncology ◽

10.1093/annonc/mdy431.029 ◽

2018 ◽

Vol 29 ◽

pp. ix37

Author(s):

M. Dazai ◽

S. Yuki ◽

K. Sawada ◽

T. Muranaka ◽

Y. Kawamoto ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Double Blind ◽

Control Phase ◽

Randomized Control

Download Full-text

HGCSG 1301: A Multicenter, Double-Blind, Randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment

Annals of Oncology ◽

10.1093/annonc/mdy151.225 ◽

2018 ◽

Vol 29 ◽

pp. v63

Author(s):

M. Nakamura ◽

Y. Komatsu ◽

T. Muranaka ◽

M. Yagisawa ◽

Y. Kawamoto ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Double Blind ◽

Control Phase ◽

Randomized Control

Download Full-text

172PD Final analysis: Phase II trial of irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer: HGCSG0902. Comparison of administration interval in cetuximab treatment

Annals of Oncology ◽

10.1016/s0923-7534(21)00330-6 ◽

2016 ◽

Vol 27 ◽

pp. ix54

Author(s):

T. Ando ◽

S. Yuki ◽

H. Nakatsumi ◽

T. Muranaka ◽

A. Hosokawa ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Final Analysis ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Analysis Phase ◽

Administration Interval

Download Full-text

Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer

Cancer Science ◽

10.1111/cas.13943 ◽

2019 ◽

Vol 110 (3) ◽

pp. 1032-1043 ◽

Cited By ~ 10

Author(s):

Tadamichi Denda ◽

Daisuke Sakai ◽

Tetsuya Hamaguchi ◽

Naotoshi Sugimoto ◽

Takashi Ura ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Japanese Patients ◽

Line Treatment ◽

Second Line

Download Full-text

172PD Final analysis: Phase II trial of irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer: HGCSG0902. Comparison of administration interval in cetuximab treatment

Annals of Oncology ◽

10.1093/annonc/mdw581.004 ◽

2016 ◽

Vol 27 (suppl_9) ◽

Author(s):

T. Ando ◽

S. Yuki ◽

H. Nakatsumi ◽

T. Muranaka ◽

A. Hosokawa ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Final Analysis ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Analysis Phase ◽

Administration Interval

Download Full-text

Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial

Digestive and Liver Disease ◽

10.1016/j.dld.2020.11.031 ◽

2020 ◽

Author(s):

Julien Taïeb ◽

Thierry André ◽

Farid El Hajbi ◽

Emilie Barbier ◽

Clémence Toullec ◽

...

Keyword(s):

Colorectal Cancer ◽

Microsatellite Instability ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Colorectal Cancer Patients

Download Full-text

Abituzumab Combined with Cetuximab Plus Irinotecan Versus Cetuximab Plus Irinotecan Alone, as Second-Line Treatment for Patients with KRAS Wild-Type Metastatic Colorectal Cancer: The Poseidon Phase I/Randomized Phase II Trial

Annals of Oncology ◽

10.1093/annonc/mdu193.8 ◽

2014 ◽

Vol 25 ◽

pp. ii107

Author(s):

E. Elez ◽

I. Kocáková ◽

T. Höhler ◽

U. Martens ◽

C. Bokemeyer ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Randomized Phase Ii

Download Full-text

Randomized Phase Ii Trial of Hange-Shasin-To Versus Placebo to Prevent Diarrhea in Patients with Metastatic Colorectal Cancer Under Iris+Bev Second-Line Treatment (Hgcsg1301)

Annals of Oncology ◽

10.1093/annonc/mdu356.73 ◽

2014 ◽

Vol 25 ◽

pp. iv541

Author(s):

H. Fukushima ◽

S. Yuki ◽

H. Nakatsumi ◽

H. Hayashi ◽

K. Harada ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Randomized Phase Ii

Download Full-text

OP-16 Chemoembolization adopting drug eluting beads preloaded with irinotecan (DEBIRI) plus cetuximab (debiritux) as second-line treatment for metastatic colorectal cancer (CRC) to the liver: Results of a clinical phase II trial

Digestive and Liver Disease ◽

10.1016/s1590-8658(13)60680-5 ◽

2013 ◽

Vol 45 ◽

pp. S253-S254

Author(s):

G. Fiorentini ◽

C. Aliberti ◽

P. Coschiera ◽

M. Tilli ◽

L. Mulazzani ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Clinical Phase ◽

Drug Eluting Beads ◽

Drug Eluting

Download Full-text

P-269 Phase II trial of Irinotecan/S-1 (IRIS) with Cetuximab (IRIS/Cet) as second line treatment in patients with KRAS WT metastatic colorectal cancer: HGCSG0902. -Comparison of administration interval in Cetuximab treatment

Annals of Oncology ◽

10.1093/annonc/mdv233.266 ◽

2015 ◽

Vol 26 ◽

pp. iv79

Author(s):

K. Hatanaka ◽

S. Yuki ◽

H. Nakatsumi ◽

A. Hosokawa ◽

M. Nakamura ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Administration Interval

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Dose Dense ◽

First Line Treatment

Download Full-text